Illuminating and Treating Diseases
Nuclear medicine involves the use of small amounts of radioactive materials (or tracers) to help diagnose and treat a variety of diseases. Nuclear medicine determines the cause of the medical problem based on the function of the organ, tissue or bone. This is how nuclear medicine differs from an x-ray, ultrasound or any other diagnostic test that determines the presence of disease based on structural appearance. More
Sanjiv Sam Gambhir Young Investigator Award
October 2024
Congratulations to this years winner, Grace Keane!
September 2023
Stanford Health Care in California received Radiopharmaceutical Therapy Accreditation by SNMMI and the Intersocietal Accreditation Commission. This is the first academic facility accredited under the program, which was launched in June to recognize proficiency and competency in radiopharmaceutical therapy.
Innovations in Radiopharmaceutical Therapies - SNMMI Podcast Series
September 2023
Dr. Stephen A. Graves and Dr. Andrei Iagaru discuss the opportunities, threats, challenges, trends, and lessons learned regarding radiopharmaceutical therapy with moderator Dr. Phillip J. Koo.
To hear podcast click here
Follow-up on the Sanjiv Sam Gambhir Young Investigator Award
September 2023
Congratulations to this years winner, Victor Hvingelby!
Utilizing AI for Quantitative Assessment of Prostate Cancer Recurrence
August 2023
In a video interview, Hong Song, MD, PhD, discussed retrospective research, presented at the recent SNMMI conference, that evaluated the combination of artificial intelligence (AI)-based software and the PSMA agent piflufolastat F 18 to help quantify prostate cancer lesions and associations with biochemical progression-free survival. Congrats Hong! |
Stanford's Second Cyclotron
July 27, 2023
"Stanford Radiology reached a significant milestone with the delivery of a General Electric (GE) PETtrace 890 Cyclotron System from Sweden, across the Atlantic Ocean and United States, to 1701 Page Mill Road in Palo Alto. This new cyclotron is part of Dr. Sam Gambhir’s broader vision for precision medicine and advancements in biology and technology for better diagnosis, improved disease prevention and early intervention..." |
EANM'23: Sanjiv Sam Gambhir Young Investigator Award - TRAILER
EANM will host the 2nd Annual EANM Sanjiv Sam Gambhir Young Investigator Award. EANM has partnered with Stanford University and kindly supported by Telix Pharmaceuticals.
Please visit the EANM'23 website for detailed information by clicking here.
SNMMI Designates First Radiopharmaceutical Therapy Centers of Excellence
March 2022
"The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Stanford Health Care and the Dana-Farber Brigham Cancer Center as its first two designated Radiopharmaceutical Therapy Centers of Excellence. The institutions are designated as comprehensive centers that administer multiple radiopharmaceutical therapies — such as those to treat thyroid cancer, prostate cancer and neuroendocrine tumors—and activelyengage in radiopharmaceutical therapy research. SNMMI created the Radiopharmaceutical Therapy Center of Excellence program to certify sites that meet strict regulatory, training, qualification, experience and performance criteria for radiopharmaceutical therapy. With the Radiopharmaceutical Therapy Centers of Excellence designation, institutions can assure patients, their families, referring physicians and payors that rigorous procedures are in place and followed, ultimately leading to appropriate patient selection and optimal outcomes from radiopharmaceutical therapy." |
Molecular Imaging: Principles and Practice, 2nd Edition
August 2021
On August 9th, 2021, the textbook Molecular Imaging: Principles and Practice, 2nd Edition, (Volumes 1 & 2) was published. This textbook was edited by Sanjiv Sam Gambhir, MD, PhD, and Brian Ross, PhD with contributions from Dr. Andrei Iagaru, Dr. Craig Levin & Dr. Farshad Moradi.
The detection and measurement of the dynamic regulation and interactions of cells and proteins within the living cell are critical to the understanding of cellular biology and pathophysiology. The multidisciplinary field of molecular imaging of living subjects continues to expand with dramatic advances in chemistry, molecular biology, therapeutics, engineering, medical physics and biomedical applications. Molecular Imaging: Principles and Practice, Volumes 1 and 2, Second Edition provides the first point of entry for physicians, scientists, and practitioners. This authoritative reference book provides a comprehensible overview along with in-depth presentation of molecular imaging concepts, technologies and applications making it the foremost source for both established and new investigators, collaborators, students and anyone interested in this exciting and important field.
Grand Opening of the Theragnostics Space in Nuclear Medicine
May 2021
The Division of Nuclear Medicine and Molecular Imaging held a ribbon cutting ceremony for the new Theragnostics space on May 13, 2021. This was a small gathering due to CoVID restrictions, but we were able to bring together colleagues and friends who contributed to the completion of this project. Many more watched the live streaming courtesy of Josh Mailman. It was an emotional evening as we recognized Dr McDougall's illustrious career, paid homage to Sam's vision and legacy and dedicated the newly opened area to Ross, Sam, the patients and their families.
We hope you will enjoy reading the brochure and watching the recording.
FDG: Forty Years of Changing Lives
Theragnostics Ribbon Cutting Ceremony
News
Faculty Promotion
March 2025
Matteo Novello, MD, was promoted to Clinical Assistant Professor in Nuclear Medicine and Molecular Imaging.
SNMMI Central Chapter Meeting
March 2025
Congratulations Helen Nadel, MD, FRCPC, FSNMMI who recieved the James J. Conway, MD Inaugural Memorial Lecturer Award!
Faculty of the Year
February 2025
Congratulations Erin Grady, MD, who recieved the Faculty of the Year Award!
Best Clinical Mentor Award
January 2025
Congratulations Erin Grady, MD, who recieved the 2025 ACNM Best Clinical Mentor Award!
Faculty Promotion
December 2024
Kip Guja, MD, PhD, was promoted to Clinical Assistant Professor in Nuclear Medicine and Molecular Imaging.
C.A.R.E Award Nursing 2024
November 2024
Cat serves as our NP in our Theragnostic clinic and sees some very complicated patients. In spite of this, she can have a strong rapport with all the patients she sees and answer their myriad questions. Cat is a tremendous asset to the department, for both patients and staff.
C.A.R.E. Award NMMI 2024
November 2024
Zach recently switched to a research coordinator who doubles as a technologist in the clinic. He is loved by all patients and the team. He always goes above and beyond his normal duties.
Tech of the Year 2024
November 2024
Chris is an exceptional technologist with extensive experience and an unwavering commitment to excellence. Not only is she a highly skilled technologist, but she is also a dedicated mentor, consistently guiding and supporting fellow technologists and residents with patience and expertise.
Interim Vice Chair Appointment
October 2024
Benjamin Franc, MD, MBA
Interim Vice Chair,
Clinical Strategy and Networks
Society of Nuclear Medicine and Molecular Imaging "Ones to Watch" 2024
May 2024
Wenhui Zhou, MD, PhD, was recognized on SNMMI's annual list of early career professionals selected as "Ones to Watch" in 2024. Congratulations Wenhui on this well deserved recognition!
Faculty Leadership Appointment
February 2024
We are delighted to announce that Erin Grady, MD, will be the new Associate Chair for Education and Diversity, Equity, and Inclusion (DEI).
Faculty Promotion
February 2024
Jagruti Shah, MBBS, has been promoted to Clinical Associate Professor in Nuclear Medicine & Molecular Imaging.